Asthma is a common chronic disease that affects people of all ages in all parts of the world. It is a cause of substantial burden of disease, including both premature death and reduced quality of life. Asthma affects an estimated 339 million individuals worldwide.
Despite the widespread availability of asthma treatment guidelines, surveys indicate that the majority of patients in both developed and developing countries do not receive optimal care and therefore their asthma is not well controlled.
South African and global guidelines for asthma aim to promote a better standard of treatment based on advances in the understanding of the pathophysiology and pharmacotherapy of asthma. The Global Initiative for Asthma (GINA) compiles an annual update of the Global Strategy for Asthma
Management and Prevention. This report provides a comprehensive and integrated approach to asthma management that can be adapted for local conditions and individual patients. The 2019 GINA report includes important new recommendations for the treatment of mild asthma and severe
This module provides an update on asthma for the pharmacist and incorporates the latest recommendations from the 2019 GINA report.